Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Laurus Labs Ltd. ( (IN:LAURUSLABS) ) has provided an announcement.
Laurus Labs Ltd. announced the availability of the audio recording for their Q2 FY26 results conference call, which was held on October 23, 2025. This update is part of their regulatory compliance and transparency efforts, providing stakeholders with access to detailed financial discussions and company performance insights.
More about Laurus Labs Ltd.
Laurus Labs Ltd. operates in the pharmaceutical industry, focusing on the development and manufacturing of active pharmaceutical ingredients (APIs), generic formulations, and biotechnology products. The company is committed to delivering high-quality healthcare solutions and has a significant presence in the global market.
Average Trading Volume: 108,996
Technical Sentiment Signal: Buy
Current Market Cap: 498.7B INR
Find detailed analytics on LAURUSLABS stock on TipRanks’ Stock Analysis page.